Purine Degradation & Gout (Musculoskeletal Block) Purine degradation pathway Fate of uric acid in humans Gout and hyperuricemia: Biochemistry Types Treatment.

Slides:



Advertisements
Similar presentations
GOUT Disease caused by tissue deposition of Monosodium urate crystals as a result of supersatuaration of extra cellular fluid with MSU.
Advertisements

Principles of Biochemistry
Purine degradation & Gout (Musculoskeletal Block) Purine degradation pathway Fate of uric acid in humans Gout and hyperuricemia: Biochemistry Types Treatment.
Functions of nucleotides in biochemistry ● Building blocks of nucleic acids ● Cosubstrates and coenzymes ● Signaling.
Copyright © 2004 Pearson Education, Inc., publishing as Benjamin Cummings Dee Unglaub Silverthorn, Ph.D. H UMAN P HYSIOLOGY PowerPoint ® Lecture Slide.
Purine Degradation & Gout (Musculoskeletal Block)
Prepared by : Tamara Odeh Diana Jawhari Supervised by : Dr. Ola Ayesh.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 74 Drug Therapy of Gout.
Nucleic acids metabolism
Gout.
Introduction.
 Gout is characterized by elevated uric acid concentrations in blood and urine due to variety of metabolic abnormalities that include overproduction.
Uric Acid Metabolism & Gout. Nucleic Acids Mononucleotide Base + Sugar + Phosphoric Acid Base: Purine or Pyrimidine Polynucleotide (DNA or RNA) Mononucleotides.
Purine degradation & Gout (Musculoskeletal Block).
Uric acid xiaoli.
Familial metabolic disease Characterized by : Acute arthritis Uric stones in the kidneys Hyperuricemia.
UNIT IV: Nitrogen Metabolism Nucleotide Metabolism Part 2.
Purine Degradation & Gout (Musculoskeletal Block)
Chapter 13 Agents Used to Treat Hyperuricemia and Gout.
Uric Acid Metabolism & Gout. Nucleic Acids Mononucleotide Base + Sugar + Phosphoric Acid Base: Purine or Pyrimidine Polynucleotide (DNA or RNA) Mononucleotides.
Uric Acid Metabolism & Gout
Gihan E-H Gawish, MSc, PhD Ass. Professor Molecular Genetics and Clinical Biochemistry Molecular Genetics and Clinical BiochemistryKSU FIFTH WEEK.
Nucleic Acid metabolism. De Novo Synthesis of Purine Nucleotides We use for purine nucleotides the entire glycine molecule (atoms 4, 5,7), the amino nitrogen.
Metabolism of purine nucleotides A- De Novo synthesis: of AMP and GMP Sources of the atoms in purine ring: N1: derived from NH2 group of aspartate C2 and.
Purine degradation & Gout (Musculoskeletal Block) Purine degradation pathway Fate of uric acid in humans Gout and hyperuricemia: Biochemistry Types Treatment.
Gout Gouty Arthritis By Mike Parenteau.
Clinical Case #6 By Chen, chun-Yu (Kim) Chen, I -chun (Afra) Chen, I -chun (Afra)
Gout Elevation of serum uric acid level: hyperuricemia primary risk factor,predisposes to gout > 6.8mg/dl Deposition of uric acid crystals (monosodium.
CHAPTER © 2012 The McGraw-Hill Companies, Inc. All rights reserved. 20 Nonopioid Analgesics, Nonsteroidal Antiinflammatories, and Antigout Drugs.
Gout Familial metabolic disease characterized by : Acute arthritis Uric acid stones in the kidneys Hyperuricemia.
Agents Used to Treat Hyperuricemia and Gout
GOUT A metabolic disease in which tissue deposition of crystals of monosodium urate occurs from supersaturated extracellular fluids and results in one.
GOUT: DIAGNOSIS AND MANAGEMENT. Gout Metabolic disorder due to excessive accumulation of uric acid in tissues leading to acute and chronic arthritis and.
Metabolism of purine nucleotides
Gout. The most common cause of inflammatory arthritis in US adults (3.9% of Americans; approx. 8.3 million people; ) Prevalence is greater in.
Metabolism of purine nucleotides A- De Novo synthesis: of AMP and GMP Sources of the atoms in purine ring: N1: derived from NH2 group of aspartate C2 and.
Salvage Pathway of Purines. Purines that result from the normal turnover of cellular nucleic acids, or that are obtained from the diet and not degraded,
Gout. The term gout describes a disease spectrum including – hyperuricemia, – recurrent attacks of acute arthritis associated with monosodium urate crystals.
GOUTY ARTHRITIS PRESENTED BY, JISMI MATHEW LINCY K OUSEPH MEENUPRIYA OONNANAL SMITHA V CHACKO VINEETHA MARY MATHEW.
Creatinine Creatinine is the waste product formed in muscle from a high energy storage compound ,creatine phosphate (phosphocreatine). ATP is the immediate.
GOUTY ARTHRITIS PRESENTED BY, JISMI MATHEW LINCY K OUSEPH MEENUPRIYA OONNANAL SMITHA V CHACKO VINEETHA MARY MATHEW.
ANTI-GOUT DRUGS. GOUT A familial metabolic disease characterized by recurrent episodes of acute arthritis due to deposits of monosodium urate in joints.
Uric acid nephropathy 신장내과 R4 최선영. Endogenous production of uric acid Purine catabolism hypoxanthine xanthine Uric acid allantoin XO UO allopurinol -
Metabolism of purine nucleotides A- De Novo synthesis: of AMP and GMP Sources of the atoms in purine ring: N1: derived from NH2 group of aspartate C2 and.
Gout Ashley Guzman Primary Care I: Acute and Chronic Health Problems
Crystalopathies Joanna Zalewska.
Gout Is recurrent inflammatory disorder characterized by
Purine degradation and Gout
Purine Degradation & Gout (Musculoskeletal Block)
Gout.
Introduction to pathology
Department of Biochemistry
Drug Therapy of Gout 1.
GOUT.
PURINE AND PYRIMIDINE DEGRADATION
  URIC ACID Muthana A. Al-Shemeri.
RUINS IN POMPEI, ITALY. RUINS IN POMPEI, ITALY.
Antiuricaemic drugs Dr A.W Olusanya.
Lecture 9 Musculoskeletal Disorders Gout
Your Patient 50 years old male comes in the emergency complaining severe pain in his big toe and ankle for the last 12 hrs. On examination joint shows.
Gout By: Patience Alley, Albert Watson, and Hunter Kimball.
Desorders of nucleotides metabolism
Pu & Py salvage Title slide..
How to Find Relief & Reduce Flare-Ups
Uric acid test By 51 Fifth Stage Student Sakar Karem Abdulla
Purine Degradation & Gout (Musculoskeletal Block)
Purine Degradation & Gout (Musculoskeletal Block)
Presentation transcript:

Purine Degradation & Gout (Musculoskeletal Block) Purine degradation pathway Fate of uric acid in humans Gout and hyperuricemia: Biochemistry Types Treatment

Purine degradation pathway The major source of dietary nucleic acids (purines and pyrimidines) is meat Purine and pyrimidine bases are absorbed by the intestine The ingested bases are mostly degraded into different products by degradation pathways These products are then excreted by the body

Dietary DNA / RNA Nucleotides Nucleosides Pancreatic nucleases Free purine bases + Ribose Nucleotidases Nucleosidases Uric acid Purine Degradation pathway Free pyrimidine bases + Ribose Malonyl CoA Pyrimidine Degradation pathway

Purine degradation pathway Adenosine and guanosine (purines) are finally degraded to uric acid by:  Purine degradation pathway

Voet Biochemistry 3e © 2004 John Wiley & Sons, Inc. Page 1093 Major pathways of purine catabolism in animals

CATABOLISM OF PURINES AMPIMP Adenosine Inosine HypoxanthineXanthine Uric acid Xanthosine XMPGMP Guanosine Guanine AMP Deaminase PNP ADA Xanthine Oxidase GDA Xanthine Oxidase NTDase

Fate of uric acid in humans In humans, primates, birds and reptiles the final product of purine degradation is uric acid Uric acid is excreted in the urine Some animals convert uric acid to other products:  Allantoin  Allantoic acid  Urea  Ammonia

Voet Biochemistry 3e © 2004 John Wiley & Sons, Inc. Degradation of uric acid to ammonia in some animals Page 1097

CATABOLISM OF PURINES AMPIMP Adenosine Inosine HypoxanthineXanthine Uric acid Xanthosine XMPGMP Guanosine Guanine AMP Deaminase PNP ADA Xanthine Oxidase GDA Xanthine Oxidase NTDase

Fate of uric acid in humans Uric acid is less soluble in water Reptiles, insects and birds excrete uric acid as a paste of crystals To save water Humans excrete uric acid in urine

Fate of uric acid in humans Humans do not have enzymes to further degrade uric acid Excessive production of uric acid causes deposition of uric acid crystals in the joints leading to:  Gout  Hyperuricemia

Gout Gout is a disease due to high levels of uric acid in body fluids 7.0 mg/dL and above Uric acid accumulates because of:  Overproduction or  Underexcretion

Gout Painful arthritic joint inflammation due to deposits of insoluble sodium urate crystals (especially big toe) Affects 3 per 1000 persons Sodium urate crystals accumulate in kidneys, ureter, joints leading to chronic gouty arthritis

Voet Biochemistry 3e © 2004 John Wiley & Sons, Inc. Sodium urate crystals in urine

Voet Biochemistry 3e © 2004 John Wiley & Sons, Inc.

Gout Inaccurately associated with overeating and drinking Alcohol used to be contaminated with lead during manufacture and storage Lead decreases excretion of uric acid from kidneys causing hyperuricemia and gout Excessive meat comsumption increases uric acid production in some individuals

Gout Two main causes Overproduction of uric acid Underexcretion of uric acid

Primary Gout Due to overproduction of uric acid Genetic abnormality in the enzymes of purine degradation Excessive production and degradation of purine bases (adenine, guanine, hypoxanthine)

Secondary hyperuricemia A variety of disorders and lifestyles cause secondary hyperuricemia Underexcretion of uric acid due to chronic renal disease Chemotherapy Excessive consumption of purine-rich foods such as meat Excessive alcohol intake

Secondary hyperuricemia Hyperuricemia does not always cause gout

Treatment To reduce pain and inflammation (analgesics, anti-inflammatory drugs) To increase uric acid excretion (uricosuric agents) To reduce uric acid production  xanthine oxidase inhibitors (Allopurinol and febuxostat)

Voet Biochemistry 3e © 2004 John Wiley & Sons, Inc. Page 1093 Major pathways of purine catabolism in animals

SUPPLEMENTARY SLIDES

Diagnostic features usually affect joints in the lower extremities (95%) onset is fast and sudden pain is usually severe; joint may be swollen, red and hot attack may be accompanied by fever, leukocytosis and an elevated ESR

Diagnosis The definitive diagnosis of gout requires aspiration and examination of synovial fluid from an affected joint (or material from a tophus) using polarized light microscopy to confirm the presence of needle-shaped monosodium urate crystals

Monosodium urate crystals

Treatment of gout- Acute attacks Acute attacks of gout are treated with anti- inflammatory agents. Colchicine, steroidal drugs such as prednisone, and nonsteroidal drugs such as indomethacin are used Colchicine depolymerizes microtubules, thus decreasing the movement of neutrophils into the affected area.

Treatment - Long term Involves lowering the uric acid level below the saturation point, thereby preventing the deposition of urate crystals Uricosuric agents- probenecid or sulfinpyrazone, that increase renal excretion of uric acid Allopurinol, an inhibitor of uric acid synthesis Allopurinol is converted in the body to oxypurinol, which inhibits xanthine oxidase, resulting in an accumulation of hypoxanthine and xanthine— compounds more soluble than uric acid and, therefore, less likely to initiate an inflammatory response

References Lippincott 4 th Edition Voet & Voet